AMBS Amarantus Bioscience Holdings Inc (CE)

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934

 

Filed by the Registrant  x

 

Filed by a Party other than the Registrant o

 

Check the appropriate box:

 

o	Preliminary Proxy Statement
o	Confidential, for the use of the Commission only (as permitted by Rule 14a-6(e)(2))
o	Definitive Proxy Statement
x	Definitive Additional Materials
o	Soliciting Material Pursuant to §240.14a-12

 

Amarantus BioScience Holdings, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

x	No fee required.
o	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:

 

o	Fee paid previously with preliminary materials.
o	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-1l (a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

	(1)	Amount Previously Paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:

 

  

The following was released by Amarantus BioScience Holdings, Inc. in its social media channels.

 

Facebook/Google+

Amarantus Bioscience, Inc.

Amarantus announced that its 2015 Annual Meeting of Stockholders scheduled for, and convened on August 3, 2015, was adjourned due to the lack of requisite quorum. The annual meeting has been adjourned to August 7, 2015, at 10:00 a.m. ET at Schizenia Ross Friedman Ference LLP, 61 Broadway, 32nd Floor, New York, New York 10006 to allow additional time for the stockholders to vote on the proposals set forth in the Company's proxy statement filed with the Securities and Exchange Commission. The Company encourages all stockholders who have not yet voted to do so before August 6, 2015 at 11:59 p.m. Click here for additional details and information: http://bit.ly/1KNvOiq

 

https://www.facebook.com/amarantusbio/posts/853619128047387

https://plus.google.com/110152688579338796390/posts/2NnGnFLy4ub

 

LinkedIn

Amarantus BioScience Amarantus announced that its 2015 Annual Meeting of Stockholders scheduled for, and convened on August 3, 2015, was adjourned due to the lack of requisite quorum. The annual meeting has been adjourned to August 7, 2015, at 10:00 a.m. ET at Schizenia Ross Friedman Ference LLP, 61 Broadway, 32nd Floor, New York, New York 10006 to allow additional time for the stockholders to vote on the proposals set forth in the Company's proxy statement filed with the Securities and Exchange Commission. The Company encourages all stockholders who have not yet voted to do so before August 6, 2015 at 11:59 p.m. http://bit.ly/1KNvOiq

 

https://www.linkedin.com/company/2467217/comments?topic=6034143003151466496&type=U&scope=2467217&stype=C&a=6cSl&goback=%2Ebzo_*1_*1_*1_*1_*1_*1_*1_*1_2467217

 

 

Amarantus BioScience

‏@AmarantusBio

Amarantus Announces Adjournment of Annual Meeting http://bit.ly/1KNvOiq  $AMBS

https://twitter.com/AmarantusBio/status/628377313713876992

 

Amarantus BioScience

‏@AmarantusBio

$AMBS annual meeting has been adjourned to 8/7 at 10:00 a.m. EDT at Sichenzia Ross Friedman Ference, LLP. Read more: http://bit.ly/1SHLr1Y

https://twitter.com/AmarantusBio/status/628566079825014784

 

$AMBS encourages all stockholders who have not yet voted to do so before August 6, 2015 at 11.59 p.m. EDT. http://ir.amarantus.com/press-releases/detail/2011

https://twitter.com/AmarantusBio/status/628630229112635392